A Novel Function of Thrombin-activatable Fibrinolysis Inhibitor during Rat Liver Regeneration and in Growth-promoted Hepatocytes in Primary Culture*

Thrombin-activatable fibrinolysis inhibitor (TAFI) exhibits anti-fibrinolytic activity by removing C-terminal lysine residues from fibrin or plasminogen receptor proteins on the cellular surface, and plays an important role in the regulation of fibrinolysis. In this study, we examined the regulation of TAFI in hepatocytes during liver regeneration, and revealed its pivotal role in hepatocyte proliferation. In rat models, partial hepatectomy or carbon tetrachloride (CCl4)-induced acute liver injury suppressed the levels of plasma TAFI activity and hepatic TAFI mRNA, whereas this operation markedly increased both the hepatic plasmin activity and the level of proliferating cell nuclear antigen. In primary cultures of rat hepatocytes, the TAFI mRNA level was decreased under growth-promoting culture conditions. Treatment of the hepatocytes with TAFI siRNA increased the amount of plasmin on the hepatocytes and promoted hepatocyte proliferation. We concluded that TAFI regulates plasmin activity through its enzymatic activity whereby it reduces the plasminogen-binding capacity of the hepatocytes. The TAFI gene expression is down-regulated in hepatocyte proliferation for producing a fibrinolytic microenvironment suitable for cell growth. This is the first report on the role of TAFI in the pericellular fibrinolysis necessary for cellular proliferation.

[1]  M. Sibilia,et al.  The EGF receptor is required for efficient liver regeneration , 2007, Proceedings of the National Academy of Sciences.

[2]  N. Okumura,et al.  Cell Surface-Bound Plasminogen Regulates Hepatocyte Proliferation Through a uPA-Dependent Mechanism , 2007, Bioscience, biotechnology, and biochemistry.

[3]  K. Okada,et al.  Plasmin decreases the BH3-only protein BimEL via the ERK1/2 signaling pathway in hepatocytes. , 2007, Biochimica et biophysica acta.

[4]  Sandrine Florquin,et al.  Absence of Thrombin-Activatable Fibrinolysis Inhibitor Protects against Sepsis-Induced Liver Injury in Mice1 , 2005, The Journal of Immunology.

[5]  M. Davies,et al.  Plasmin Induces Smooth Muscle Cell Proliferation1,2 , 2005 .

[6]  U. Pendurthi,et al.  A novel mechanism of plasmin‐induced mitogenesis in fibroblasts , 2005, Journal of thrombosis and haemostasis : JTH.

[7]  M. Daveau,et al.  Expression of a Functional C5a Receptor in Regenerating Hepatocytes and Its Involvement in a Proliferative Signaling Pathway in Rat1 , 2004, The Journal of Immunology.

[8]  John D Lambris,et al.  C3a and C3b Activation Products of the Third Component of Complement (C3) Are Critical for Normal Liver Recovery after Toxic Injury1 , 2004, The Journal of Immunology.

[9]  P. Carmeliet,et al.  Plasminogen mediates liver regeneration and angiogenesis after experimental partial hepatectomy , 2003, The British journal of surgery.

[10]  I. B. Borel Rinkes,et al.  Impaired healing of cutaneous wounds and colonic anastomoses in mice lacking thrombin‐activatable fibrinolysis inhibitor , 2003, Journal of thrombosis and haemostasis : JTH.

[11]  N. Okumura,et al.  Plasminogen activator/plasmin system regulates formation of the hepatocyte spheroids. , 2003, Biochemical and biophysical research communications.

[12]  C. Clerici,et al.  Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis , 2003, Hepatology.

[13]  J. Meijers,et al.  Thrombin‐activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U) , 2003, Journal of thrombosis and haemostasis : JTH.

[14]  M. Boffa,et al.  Acute Phase Mediators Modulate Thrombin-activable Fibrinolysis Inhibitor (TAFI) Gene Expression in HepG2 Cells* , 2003, The Journal of Biological Chemistry.

[15]  Y. Takada,et al.  Plasmin-induced Migration of Endothelial Cells , 2002, The Journal of Biological Chemistry.

[16]  N. Okumura,et al.  Plasminogen activator-plasmin system potentiates the proliferation of hepatocytes in primary culture. , 2002, Thrombosis research.

[17]  Ping Wang,et al.  The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation. , 2002, Biochimica et biophysica acta.

[18]  H. Okada,et al.  Inactivation of C3a and C5a Octapeptides by Carboxypeptidase R and Carboxypeptidase N , 2002, Microbiology and immunology.

[19]  T. Seki,et al.  Induction of hepatic tissue-type plasminogen activator and type 1 plasminogen activator-inhibitor gene expressions and appearance of their translation products in the bile following acute liver injury in rats. , 2001, Thrombosis research.

[20]  T. Syrovets,et al.  Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKKbeta-mediated NF-kappaB activation. , 2001, Blood.

[21]  D. V. van Thiel,et al.  Low Levels of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Patients with Chronic Liver Disease , 2001, Thrombosis and Haemostasis.

[22]  T. Bugge,et al.  Plasminogen activators direct reorganization of the liver lobule after acute injury. , 2001, The American journal of pathology.

[23]  L. Bajzar.  Thrombin Activatable Fibrinolysis Inhibitor and an Antifibrinolytic Pathway , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[24]  H. Okada,et al.  Pro-Carboxypeptidase R is an Acute Phase Protein in the Mouse, Whereas Carboxypeptidase N Is Not1 2 , 2000, The Journal of Immunology.

[25]  H. Moriwaki,et al.  Control of cyclins, cyclin-dependent kinase inhibitors, p21 and p27, and cell cycle progression in rat hepatocytes by extracellular matrix. , 2000, Journal of hepatology.

[26]  D. Witte,et al.  Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Shafer,et al.  Characterization of Plasmin-mediated Activation of Plasma Procarboxypeptidase B , 1999, The Journal of Biological Chemistry.

[28]  N. Tygstrup,et al.  Growth factors and gene expression in cultured rat hepatocytes. , 1999, Journal of hepatology.

[29]  P. A. von dem Borne,et al.  Plasma TAFI Levels Influence the Clot Lysis Time in Healthy Individuals in the Presence of an Intact Intrinsic Pathway of Coagulation , 1998, Thrombosis and Haemostasis.

[30]  S. Friedman,et al.  Molecular regulation of hepatic fibrogenesis. , 1998, Journal of hepatology.

[31]  H. Ishii,et al.  Thrombomodulin in Human Plasma Contributes to Inhibit Fibrinolysis through Acceleration of Thrombin-dependent Activation of Plasma Procarboxypeptidase B , 1998, Thrombosis and Haemostasis.

[32]  D. Stolz,et al.  Extracellular matrix remodeling at the early stages of liver regeneration in the rat , 1997, Hepatology.

[33]  J. Morser,et al.  TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin Complex* , 1996, The Journal of Biological Chemistry.

[34]  D. Eaton,et al.  Plasma carboxypeptidases as regulators of the plasminogen system. , 1995, The Journal of clinical investigation.

[35]  A. Kakinuma,et al.  Laminin-rich extracellular matrix maintains high level of hepatocyte nuclear factor 4 in rat hepatocyte culture. , 1995, Biochemical and biophysical research communications.

[36]  K. Hajjar.  Cellular Receptors in the Regulation of Plasmin Generation , 1995, Thrombosis and Haemostasis.

[37]  M. Nesheim,et al.  Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor (*) , 1995, The Journal of Biological Chemistry.

[38]  K. Mizuno,et al.  Cell density-dependent regulation of hepatocyte growth factor receptor on adult rat hepatocytes in primary culture. , 1993, Journal of biochemistry.

[39]  A. Ben-Ze'ev,et al.  Cell-cell and cell-matrix interactions differentially regulate the expression of hepatic and cytoskeletal genes in primary cultures of rat hepatocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[40]  T. Nakamura,et al.  Density-dependent growth control of adult rat hepatocytes in primary culture. , 1983, Journal of biochemistry.

[41]  D. Wall,et al.  Isolation of rat hepatocyte plasma membranes. I. Presence of the three major domains , 1983, The Journal of cell biology.

[42]  Toshikazu Nakamura,et al.  BIOCHEMICAL FUNCTIONS OF ADULT RAT HEPATOCYTES IN PRIMARY CULTURE * , 1980, Annals of the New York Academy of Sciences.

[43]  E. Dowdle,et al.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. , 1980, Analytical biochemistry.

[44]  N. Aoki,et al.  Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. , 1976, The Journal of biological chemistry.

[45]  K. Okada,et al.  The regulation of liver regeneration by the plasmin/α2-antiplasmin system , 2004 .

[46]  P. Carmeliet,et al.  Impaired liver regeneration after partial hepatectomy in plasminogen deficient mice , 2001 .